logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. A model to estimate the potential economic benefits of measles eradication for the United States.

    Article - En anglais

    Measles incidence is at a nadir in many parts of the world due to vaccination efforts.

    Although the technical feasibility of eradication has been acknowledged, financial and political commitment need to be concomitantly identified on the national and global level.

    We demonstrate the potential value of measles eradication by identifying the potential cost-savings to one country resulting from measles eradication.

    For the US, measles eradication would save $45 million annually.

    If achieved by the year 2010, the US would save $500 million to $4.1 billion depending on the year of elimination post-eradication schedule and discount rate.

    Intensification of measles control efforts in the US beyond current levels would have minimal marginal benefits on disease burden reduction.

    Allocation of resources to achieve global measles eradication is the next level of efficiency which would provide substantial savings.

    Countries may adapt this model to estimate their savings for consideration of the required political and financial contribution towards a global measles eradication program.

    Mots-clés Pascal : Rougeole, Virose, Infection, Vaccination, Eradication, Analyse avantage coût, Etats Unis, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Measles, Viral disease, Infection, Vaccination, Eradication, Cost benefit analysis, United States, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0055615

    Code Inist : 002B05A02. Création : 31/05/1999.